The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome
about
Towards tumor immunodiagnosticsThe transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcomeExpression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy.Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma.A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitorsCD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung CancerKIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients.Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms.The role of dendritic cells in cancer.Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.Human Lung Mononuclear Phagocytes in Health and Disease.In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide.CD207+/langerin positive dendritic cells in invasive and in situ cutaneous malignant melanoma.Melanomas and Dysplastic Nevi Differ in Epidermal CD1c+ Dendritic Cell Count.Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaCirculating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer.Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma.Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.Immunomethylomics: A Novel Cancer Risk Prediction Tool.Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma.Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer.Effect of A549 neuroendocrine differentiation on cytotoxic immune response.Adenoviral vectors transduce alveolar macrophages in lung cancer models.The immune contexture of hepatocellular carcinoma predicts clinical outcome.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune MarkersImmunogenic effects of chemotherapy-induced tumor cell deathPrognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung CancerIntratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations
P2860
Q26738691-713EC2C8-735F-431A-88A4-949EFE7ED45DQ29248715-5C2531E6-80F4-44D0-9E3C-ACB466FB186FQ33586463-D518D548-F6B3-4ACC-A44B-BB69C6D89538Q35757467-B234D642-B941-4577-9146-5E8D5DA766B9Q35790271-597637E9-C8EC-49EE-A3CE-D67E75B3A2B0Q35873571-84DC843C-CF7D-4D3C-8772-CF54F910792BQ36184759-A808D295-B028-47AD-A597-067948733265Q36378871-9041359F-90E2-4FEA-85A2-2022BCC9E2D3Q36656039-FDE102B0-2C8E-40A6-B729-D9748C3C1A99Q36819651-7A8B03E3-6EB5-4275-8441-7694E762A770Q37516448-E679A420-D168-4F9E-8538-9FE5639C9BC4Q37520487-CBE2235E-6F1A-4E95-BC86-1785862B47F4Q37616484-7DA14DE6-F671-44F2-8F02-15B265646745Q37687799-81AE73AC-8FC3-489E-B444-5AAFF2ACB1A2Q38636708-9E14DC78-F816-4372-98AA-CB6ADE002FB1Q38699858-F147EC63-54C6-4D5B-810E-D3101D792C36Q38957065-0DB2F52B-8675-482D-B941-EDC25BE4FC32Q38961444-6BD420A1-CA66-47CE-A0F5-90F762979156Q39132282-2E639F21-EB01-49A0-9FC0-3E35611828BEQ39308555-98311567-A131-4057-8C2C-2F14152D8F1FQ40493152-31D10261-49F3-4D12-96CB-82BF247B5823Q42202119-7C6BA868-5764-4B98-B024-73170E90AA9AQ42317065-D7C6CB57-E647-46A6-8660-3CA81A9DA19DQ46241190-BE7FA4CF-E62B-4CF6-A90F-0899A3F26256Q46540302-EE4F05D7-485C-47EB-AE25-A0158B6ED0C4Q47121916-AE2F3CEE-C293-45DB-A4BA-F06807F8A7E2Q47157214-85681DE0-F354-4920-B470-435936148F95Q47581436-6B6865BE-0FCB-4922-A38F-0D6ECA848DCDQ50634571-E2F54C89-35A3-4DE2-A7A9-FFAF92F6AB5AQ52574828-20FC03D3-903E-4F98-8F86-80716267E609Q52676427-078630DE-2482-46FE-9A93-EDE0C54FD5BCQ52886428-062D8D64-07D3-478A-8B91-C94986ED2A7EQ55032457-6BA7109E-530F-4201-9879-427155E37CEEQ55035684-A3E41147-EAC9-4780-82B7-C321DA405304Q55180095-54DFBC0C-4500-4634-B731-B0E51E500C2FQ56892179-A19C72F2-CEFF-4ED7-A6DF-421A7789F6DFQ57497508-067188C0-95CF-49FF-81DC-E314B96765FAQ58122079-E7E4E19D-D2FB-4B00-A4A0-0B4110DFE00BQ58407647-978B7E82-67A0-430D-880D-C9FB0745F1E1
P2860
The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The non-small cell lung cancer ...... cteristics and patient outcome
@en
type
label
The non-small cell lung cancer ...... cteristics and patient outcome
@en
prefLabel
The non-small cell lung cancer ...... cteristics and patient outcome
@en
P2093
P2860
P50
P1476
The non-small cell lung cancer ...... cteristics and patient outcome
@en
P2093
Christian Becker
Jorge E Gomez
Miriam Merad
Nasser K Altorki
Romain Remark
Sacha Gnjatic
Wolf-Herman Fridman
P2860
P304
P356
10.1164/RCCM.201409-1671PP
P407
P50
P577
2015-02-01T00:00:00Z